Complementary Therapy: 13 Real Stories

13 stories match complementary therapy. 9 of them mention chemotherapy.

Angie, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Angie's Patient Story

Patient Info: Angie Brice Hessbruegge, Female, Under 40 | Stage IV

Angie remained on chemotherapy and focused on parenting, counseling, faith, and long-term survivor stories while living with Stage IV lung cancer.

LUNGevity
OutcomeCare Ongoing
Rhonda, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Rhonda's Patient Story

Patient Info: Rhonda Schaller, Female | Stage IV

Rhonda was living with metastatic breast cancer through periods of progression and changing treatment lines, using meditation and mindfulness to manage uncertainty and protect quality of life.

breastcancer.org
OutcomeLiving With Cancer
Iris, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Iris's Survivor Story

Patient Info: Iris, Female | Stage I

Biomarkers: 100% hormone-dependent; genetic testing negative at age 43

Iris had Stage I 100% hormone-dependent breast cancer removed surgically in 2021, followed by re-operation for a 1 mm residual area; later examinations showed no trace of cancer while she continued dietary and lifestyle changes.

Cancer et Métabolisme
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

Inoperable small cell lung cancer with brain metastases and treatment response

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: Brain

After chemotherapy, radiation, and adjunct metabolic/complementary measures, the patient’s lung tumor shrank by 24%, later brain metastases disappeared on control scan, and arm function improved.

Cancer et Métabolisme
OutcomeResponding Well
SI
Lung Cancer

Stage IV Small Cell Lung Cancer: Sylvane's Patient Story

Patient Info: Sylvane, Female, 70+ | Stage IV

Metastatic Site: Bone; adrenal glands

After 3 chemotherapy cycles for Stage IV SCLC, Sylvane’s lung tumor had shrunk by half and bone and adrenal metastases had completely regressed, with a final chemo-immunotherapy cycle and then immunotherapy planned.

Cancer et Métabolisme
OutcomeResponding Well
SH
Breast Cancer

Sarah: hormone-dependent grade 1 breast cancer with individualized treatment decisions

Patient Info: Sarah, Female, 50s

Biomarkers: Hormone-dependent

Sarah’s June 2020 MRI showed that previously visible breast nodules were no longer present after metabolic measures and an oncologist-prescribed regimen including hormone suppression, cyclophosphamide, and palbociclib.

Cancer et Métabolisme
OutcomeResponding Well
HB
Breast Cancer

Hormone-dependent bifocal invasive lobular breast cancer with nodule disappearance after follow-up

Patient Info: Anonymized, Female, 50s

Biomarkers: Hormone-dependent; grade II

A 59-year-old patient with hormone-dependent grade II bifocal invasive lobular carcinoma reported nodule shrinkage after 9 months and disappearance of both nodules on ultrasound and mammogram after 12 months, while continuing 3-monthly monitoring.

Cancer et Métabolisme
OutcomeCancer-Free / NED
AL
Lung Cancer

Aggressive lung cancer with bone metastases and concurrent localized breast cancer

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: Bone: skull, spine, clavicle

The patient was still receiving carboplatin and Taxol for aggressive lung cancer with bone metastases, while her caregiver reported rapid clinical improvement, pain relief, disappearance of a visible forehead metastasis, and 1 cm reduction in a concurrent localized breast tumor.

Cancer et Métabolisme
OutcomeResponding Well
Silvia, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Silvia's Patient Story

Patient Info: Silvia Litsching, Female, 60s | Stage IV

Metastatic Site: Bone | Liver

Silvia lived for many years with metastatic breast cancer involving bone and liver, receiving repeated systemic, radiation, liver-directed, bone-directed, complementary, and rehabilitation-based care while remaining active and positive.

Krankheitserfahrungen.de
OutcomeLiving With Cancer
Richard, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Richard's Survivor Story

Patient Info: Richard Linde, Male, 60s | Stage IV

Metastatic Site: Liver

As of spring 2013, Richard had completed surgery for the bowel tumor, surgery for a liver metastasis, and chemotherapy, while managing lasting fatigue and continuing follow-up with a reduced work model.

Krankheitserfahrungen.de
OutcomeSurvivorship / Completed Treatment
Lisa, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Lisa's Survivor Story

Patient Info: Lisa Roth, Female, 50s

Biomarkers: Lynch syndrome / HNPCC

By winter 2012/2013, Lisa was free of metastases and recurrence after surgery for Lynch syndrome-associated colorectal cancer, and she had become active in hereditary colorectal cancer self-help.

Krankheitserfahrungen.de
OutcomeCancer-Free / NED
Anna, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Anna's Patient Story

Patient Info: Anna Rusch, Female, 70+ | Stage IV

Metastatic Site: Lung; ovary; liver

By December 2012, Anna was living with metastatic colon cancer, a permanent end stoma, and ongoing treatment for metastases in the lung, ovaries, and liver after repeated operations and chemotherapy.

Krankheitserfahrungen.de
OutcomeSetback / Progression
Lauren, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV KRAS Colorectal Cancer: Lauren's Patient Story

Patient Info: Lauren Bimage, Female, Under 40 | Stage IV

Biomarkers: Patient-reported KRAS-mutated colon cancer

Metastatic Site: chest; abdominal/peritoneal lining; spine/back

As of September 2024, Lauren was living with both Stage IV breast cancer and Stage IV colon cancer. Colon cancer markers were described as low/normal, while biopsy showed the persistent back/spine disease was breast cancer.

The Patient Story
OutcomeLiving With Cancer